• Skip to primary navigation
  • Skip to main content
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • SAGES Store
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
    • “Unofficial” Logo Products
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2024 Scientific Session Call For Abstracts
      • 2024 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Fellows Career Development Course
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • OWLS
  • Log In

Alvimopan use in colorectal resection patients

Erica Pettke1, Abhinit Shah1, Vesna Cekic1, Daniel Feingold2, Tracey Arnell2, Nipa Gandhi1, Carl Winkler, MD1, Richard Whelan1. 1Mount Sinai West, 2Columbia University

Introduction: Alvimopan (Alvim) is a peripherally acting µ-opioid receptor antagonist used to accelerate gastrointestinal functional recovery postoperatively (postop) after bowel resection.  The purpose of this retrospective study was to compare the time to first flatus and bowel movement (BM) as well as length of stay (LOS) following elective minimally invasive colorectal resection (CRR) in a group of patients (pts) who received alvimopan perioperatively (periop) vs a group that did not get this agent.

Methods: A data review from 2000-2015 from 2 IRB approved databases was carried out.  Operative, hospital and office charts were reviewed.  Routine use of Alvim for elective CRR cases was stared in 2013. Besides GI data, preoperative comorbidities and 30 day postop complication rates were assessed. The results with periop Alvim were compared to a no-Alvim group. The Students T and Chi-Square tests were used.

Results: A total of 902 pts underwent elective CRR.  Alvim was administered periop to 262 pts (29%).  The breakdown of indications between groups were similar. Alvim pts were younger (60.4 vs. 63.8 years old, p = 0.002) and, as regards comorbidities, less likely to have heart disease (CAD 4.1% vs 13.9%, other heart disease 13.2% vs 19.5%) but were otherwise similar. The rate of laparoscopic-assisted (Alvim, 80.9%; No Alvim, 68%) and hand assisted or hybrid operations (Alvim,  19.1%; No Alvim,  32%) were similar.  Alvim pts had significantly earlier return of flatus (2.4 vs 2.9 days) and first BM (2.6 vs 3.5, p<0.001 for both) than the No Alvim group.  There was also a trend toward a shorter LOS (6.1 vs 6.7 days, p=0.05) for the Alvim group.  Overall complication rates were similar, however, Alvim pts had lower rates of post-operative ileus (5.3% vs 14.1%, p < 0.0002), sSSI’s (5.8 vs 10%, p=0.04), and blood transfusion (7.1 vs 13.0%, p=0.01) than the No Alvim group.

Conclusion: The two groups compared were largely similar (most co-morbidities, indications, CRR type) with the differences in age and cardiac issues noted.  The impact of the higher rates of sSSI’s, blood transfusion, and MI in the no Alvim group on GI function is unclear.  Pts who received Alvim periop had an accelerated return of bowel function, decreased postoperative ileus and shorter length of stay.  These results suggest that Alvim is effective in reducing the postoperative ileus but further study is warranted.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 87549

Program Number: P281

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

49

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064
1-310-437-0544
[email protected]
Monday - Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons